Remember when President Obama's byline popped up in The Wall Street Journal with a warning about the build-up of regulatory gunk in the country's economy? In a number of instances, he wrote, federal ...

Government agencies at the state and federal levels are increasingly training their sights on the cybersecurity resiliency of companies in an array of industries. The US Securities and Exchange ...

A growing divide between researchers and regulators over the use of biomarkers as surrogate endpoints is influencing drug approval timelines. Recent FDA decisions, including a rejection of a gene ...